Bernie Sanders keeps the heat on Novo’s high prices
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: drug prices
FDA formalizes protocol for international cancer trials
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The essential biotech updates of the day
Morning! Today, we talk about bioethics, catch up on some reports from ESMO, and wonder aloud…
Can GLP-1 drugs help with type 1 diabetes?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Moderna cuts spending, and Sarepta’s ‘curse’ on Califf
Good morning. If you’re following the European Society for Medical Oncology meeting that starts tomorrow,…
Eli Lilly releases new data on weekly insulin
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Five biotech news stories you need to read today
Morning! Today, we’ll keep riding the bispecific wave, and tell you what Verily and FDA…
Terns’ GLP-1 pill leads to weight loss in early study
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Lilly has more positive data on its weekly insulin
Want to stay on top of the science and politics driving biotech today? Sign up to get…
BioMarin’s big day today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Health care price regulation is undemocratic
The Biden administration recently announced that it will use taxpayer dollars to “stabilize” Medicare Part…
Genentech is shedding even more employees
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Hims takes a blow from Lilly’s vial news
Good morning. As a treat for Labor Day weekend, we’re running a deal for STAT+…
Pfizer and Lilly want to sell you drugs directly
Want to stay on top of the science and politics driving biotech today? Sign up to get…
A Galapagos investor signals impatience with its turnaround efforts
Want to stay on top of the science and politics driving biotech today? Sign up to get…
5 health issues to watch for at the Democratic National Convention
WASHINGTON — Democrats have set the stage for a convention this week packed with boasts…
Opinion: STAT+: What the newly released Medicare prices for 10 drugs do and don’t tell us
For many of us, Thursday was Health-Policy-Wonk Festivus. The Centers for Medicare & Medicaid Services…
Is pharma still fearful of the Inflation Reduction Act?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Listen: Drug pricing drops & psychedelics under fire
Are pharma companies still fearful of the Inflation Reduction Act? Will Lykos’ FDA rejection and…
We have mpox vaccines now. But how will they be distributed?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Arthritis patients resort to an inconvenient Medicare workaround to avoid pricey drugs
As many as 40,000 chronically ill seniors are choosing to endure uncomfortable, time-consuming intravenous infusions…
Syros shares battered after it stops leukemia trial
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The politics of mifepristone in the 2024 election
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Atai advances oral psychedelic in depression
Want to stay on top of the science and politics driving biotech today? Sign up to get…
A tough week for MDMA-assisted psychotherapy
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Some ‘inconvenient’ truths about pharmacy benefit managers
Pharmacy benefit managers have been in the crosshairs of late, as the focus of media…
Why did Novo pull heart failure paperwork for Wegovy?
Hey, humans. Today, we talk about the decades-long pursuit to get MDMA approved as a…
STAT+: Judge rules against Chamber of Commerce in Medicare drug negotiation lawsuit
WASHINGTON — A federal judge on Thursday tossed out a U.S. Chamber of Commerce lawsuit…
STAT+: A strong start for Madrigal’s MASH drug launch
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
Sarepta CEO: We’re ‘pretty brilliant’
Want to stay on top of the science and politics driving biotech today? Sign up to get…
A new drug for glioma means a windfall for Agios
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Harris’ reported running mate, Minnesota Governor Tim Walz, boasts progressive health care record
WASHINGTON — With Minnesota Gov. Tim Walz as her running mate, Vice President Kamala Harris…
The exclusive biotech stories you need to read
Want to stay on top of the science and politics driving biotech today? Sign up to get…
FDA ad comm favors Zevra’s Niemann-Pick drug
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Medicare scrambles to keep prescription drug plan premiums stable ahead of elections
WASHINGTON — Medicare officials are offering private insurers big subsidies to keep premiums for prescription-drug…
Moderna is still in a Covid hangover
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: On Andrew Left and the government’s fraud case
I love the Summer Olympics. Every four years I transform into a huge fan of…
venBio raises $528 million for its fifth fund
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The debate over how long to use Alzheimer’s drugs
Good morning. We have a new investigation out today about how Mount Sinai in New…
Opinion: Cost counseling and stewardship need to be part of medical school curricula
In my third week as a medical intern, I learned a vital lesson about the…
STAT+: Wells Fargo faces class action lawsuit over workers’ high drug costs
Former employees sued Wells Fargo on Tuesday, alleging the banking giant violated federal law by…
Testing GLP-1s in Alzheimer’s, and is Medicare a good negotiator?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: How to tell if Biden drove a hard bargain on drug prices
WASHINGTON — The deadline for announcing how much Medicare lowered drug prices in the first…
The biotech news you need from the weekend
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Mark Cuban’s company won’t fix drug costs, but it can still help rectify America’s drug shortages
Americans are facing at least two prescription drug crises simultaneously. One is the outrageously high…
The worst for Dexcom may not be over
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: A preview of Neurocrine’s muscarinic drug readout
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
A potential rival for Wegovy and Zepbound enters the fray
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Merck lays off workers amid rough pharma job market
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: House hearing keeps pressure on PBM practices while Congress considers reforms
The House Oversight Committee kept pressure on drug middlemen at a hearing today that focused…